ovarian cancer

Ovarian cancer is usually diagnosed only after it has reached an advanced stage, with many tumors spread throughout the abdomen. Most patients undergo surgery to remove as many of these tumors as possible, but because some are so small and widespread, it is difficult to eradicate all of them. Researchers at MIT, working with surgeons… Read more

Administering a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed. The combination of vistusertib along with paclitaxel (Taxol) chemotherapy caused tumours of over half of patients with ovarian cancer and over a third with lung… Read more

A team of researchers has found that a treatment using bioadhesive nanoparticles loaded with a potent chemotherapy drug proved more effective and less toxic than conventional treatments for gynecological cancer. The work was led by professor Mark Saltzman at the Yale School of Engineering and Applied Science and professor Alessandro Santin at the Yale School… Read more

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team led by researchers from Boston Children’s Hospital’s Vascular Biology Program, the University of Bergen and Weill Cornell Medical College. The peptides, dubbed psaptides, stimulate a response… Read more

The debate about whether or not talcum powder causes ovarian cancer has rumbled on for decades. However, it recently reached fever pitch after a US court awarded damages to the family of a woman who died of ovarian cancer, allegedly as a result of having used talc as a feminine hygiene product for many years… Read more